Cambior pares its loss, adopts poison pill plan

Cambior (CBJ-T, CBJ-X) trimmed its losses by nearly two thirds during the recent third quarter thanks largely to its non-gold operations. The company posted a net loss of US$2.2 million (or a penny a share) on revenue of US$91.7 million,...

By continuing to browse you agree to our use of cookies. To learn more, click more information

Dear user, please be aware that we use cookies to help users navigate our website content and to help us understand how we can improve the user experience. If you have ideas for how we can improve our services, we’d love to hear from you. Click here to email us. By continuing to browse you agree to our use of cookies. Please see our Privacy & Cookie Usage Policy to learn more.

Close